Changing concepts in the management of pathological and impending pathological fractures.
The benefits in the management of pathological fractures by internal fixation are well recognized. However, failures in bone or metal can occur where there is a large amount of bone destruction. Seven of 69 pathological fractures in our series were treated by internal fixation with adjunctive use of methylmethacrylate without failure. This allowed for secure fixation in fractures with large amounts of bone destruction, thus decreasing the patient's pain and allowing earlier mobilization. Neither the effects of radiotherapy on bone involved with neoplasm nor methylmethacrylate are altered when radiotherapy is used after internal fixation and adjunctive use of methylmethacrylate. We believe that an aggressive program of stabilization of these fractures or fixation before actual fracture provides significant patient benefits including reduction of pain, decreased length of hospital stay, reduction of financial expense, and return to as near normal function as possible.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005264:Femoral Fractures / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D005265:Femoral Neck Fractures / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D005593:Fracture Fixation, Internal; D005598:Fractures, Spontaneous / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D008297:Male; D008768:Methylmethacrylates / Q000627:therapeutic use*; D008875:Middle Aged
D008768:Methylmethacrylates